Artificial Intelligence-assisted HER2 Expression Assessment in Urothelial Carcinoma Based on Imaging-pathology Omics | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Artificial Intelligence-assisted HER2 Expression Assessment in Urothelial Carcinoma Based on Imaging-pathology Omics	Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, carcinoma, disease, epithelial neoplasm, neoplasm, transitional cell carcinoma	Enrolling by invitation	Not stated	2026-03-06		NCT07454941

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center	23
Cancer Institute and Hospital, Chinese Academy of Medical Sciences	294
First Hospital of China Medical University	92
Huadong Hospital	23
Huaxi Hospital	5
RenJi Hospital	264
Shanxi Province Cancer Hospital	43
The First Affiliated Hospital of Anhui Medical University	85
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine	91

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
National Cancer Center / Cancer Hospital, Chinese Academy of Medical Sciences Beijing	Beijing	China	1